| Iu Health Workplace Services | |
|
104 Church St Lizton IN 46149-9248 | |
| (317) 994-4110 | |
| (317) 994-6299 |
| Full Name | Iu Health Workplace Services |
|---|---|
| Speciality | Clinic/center |
| Location | 104 Church St, Lizton, Indiana |
| Authorized Official Name and Position | Geraldine Darroca (MEDICAL DIRECTOR) |
| Authorized Official Contact | 3179631618 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Iu Health Workplace Services 950 N Meridian St Suite 950 Indianapolis IN 46204-1077 Ph: (317) 963-1616 | Iu Health Workplace Services 104 Church St Lizton IN 46149-9248 Ph: (317) 994-4110 |
| NPI Number | 1508218041 |
|---|---|
| Provider Enumeration Date | 07/08/2016 |
| Last Update Date | 07/08/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508218041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
Researchers from Tufts University devised a novel experiment wherein they engineered beta cells of the pancreas and transplanted these cells onto the pancreas of diabetic mice. This resulted in two to three times insulin production by the diabetic mice that helped them control their blood sugar. These transplanted cells could be controlled using light exposure explained scientists, making this a path breaking study for diabetics.
The onset of the current COVID-19 pandemic revealed the seventh known pathogenic human coronavirus, SARS-CoV-2.
Shire plc and Meritage Pharma, Inc. announced today that Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.
Micell Technologies,™ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStent™ Drug-Eluting Coronary Stent System (MiStent DES).
› Verified 1 days ago
Hometown Family Medicine Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 103 W Main St, Lizton, IN 46149 Phone: 317-520-2926 Fax: 585-312-6697 | |
Lizton Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1045 Wyatt Way, Lizton, IN 46149 Phone: 317-994-6600 Fax: 317-994-6605 |